性发育差异患者的临床诊疗路径
过去十年,用于性发育差异(DSD)分子遗传诊断的产前和产后检测大幅扩展,医学管理更强调患者自主权、整体照护和心理社会支持。本文通过两例常见DSD病例讨论这些变化,强调诊疗原则需转化为符合患者社会文化背景的临床路径,并结合当地医疗资源和共享决策进行个体化处理。
要点
- DSD分子遗传检测选择增多,诊断需结合产前与产后检测。
- 医学管理转向患者自主权、整体照护与心理社会支持。
- 诊疗路径应适配患者社会文化背景与当地医疗资源。
核心结论
- DSD诊疗需在共享决策和临床指南基础上,结合当地设施与社会背景进行个体化处理,以实现最佳结局。
研究设计与样本
- 本文为临床病例讨论,通过两例常见DSD病例阐述诊断与医学管理原则。
主要发现
- 过去十年DSD分子遗传诊断的产前和产后检测大幅扩展。
- DSD医学管理更强调患者自主权、整体照护和心理社会支持。
临床怎么用
- 将通用DSD诊疗原则转化为符合患者及其照护者社会文化背景的临床路径。
- 考虑全球医疗组织与资源可及性差异,基于共享决策和当地指南进行个体化管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Available prenatal and postnatal tests for obtaining a molecular genetic diagnosis for differences of sexual development (DSD) have largely expanded over the last decade. More importantly, the medical management of these conditions has taken a different approach, with greater emphasis on patient autonomy, holistic care, and psychosocial support. These changes are illustrated through the discussion of 2 cases with a common form of DSD. While the principles and recommendations for the diagnosis and medical management of DSD are universal in nature, they need to be translated into clinical care pathways that align with the specific sociocultural background of patients and their caregivers to ensure the best possible outcome. Considering the inherent global differences in the organization and accessibility of health care and available resources, this requires an individualized approach based on shared decision-making and clinical guidelines that are in line with local facilities and societal context.
引用
- Syryn H, De Baere E, Cools M, et al. Approach to the Patient With a Difference of Sexual Development. J Clin Endocrinol Metab. 2025. PMID: 40602781. doi:10.1210/clinem/dgaf386
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。